Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$13.4

Avg closing price
Price range

2 John Paulson Halozyme Therapeutics Trades

John Paulson started to build up the position in Halozyme Therapeutics in Q2 2017. Since then they sold 111 Thousand shares. The investor sold all their shares in Q3 2017 and doesn't own any shares in Halozyme Therapeutics anymore.

Avg closing price
Price range
Sold -111 Thousand shares Q3 2017
Avg closing price $13.54
Price range $11.76 - $17.40
New holding (+111 Thousand shares) Q2 2017
Avg closing price $13.36
Price range $11.80 - $14.89

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!